CliniSys announced that Mark Spencer has joined the company as Senior Vice President of Global Strategy. A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.
As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University Hospital Brandenburg an der Havel (Brandenburg, Germany) have signed a 10-year strategic partnership to renew and expand the hospital's diagnostic and therapy options through the delivery of advanced technology solutions.
System C is close to completion on its £200m five-year investment programme in the Medway EPR, a patient management and electronic patient record system designed and built specifically for the NHS. The company is preparing for the nationwide launch of CareFlow EPR at three virtual events in February, March, and April 2022, with live demonstrations and learnings from those pioneering the use of the new system.
The game, out today on iOS and Android and available in English, Spanish, Catalan and Italian, is the result of a two-and-a-half-year long citizen science project developed by a team of researchers at the Centre for Genomic Regulation (CRG), the Centro Nacional de Análisis Genómico (CNAG-CRG) and game professionals.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company's cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.